During the past budget period, the Birmingham CFAR has played a major role in the development of new programmatic areas both in basic and clinical AIDS research at UAB. This was accomplished by fostering in-house AIDS research through competitive Development Grant Program and by recruitment of high caliber AIDS scientists from other institutions. Through these efforts, a considerable number of new research programs was initiated, the great majority of which have gone one to become competitive at a national level. Development Grant Program: Developmental moneys ($246,500) were used to competitively fund 8 New Investigators, 5 Pilot Projects, and one Interdisciplinary Program. This were selected from a total of 44 applications submitted to the CFAR Developmental Grant Program. Applications were prepared according to NIH guidelines, reviewed by an internal review committee, and funded solely based on scientific merit. Of the 14 competitive applications, 12 were subsequently submitted to national funding agencies, and 8 received extramural funding with total Direct Costs exceeding $13 million (3 applications are still pending review). Of the 30 non-funded proposals, 15 were submitted to alternative funding agencies, and four of these received extramural funds exceeding $800,000. The Developmental grant program has thus been extremely successful in facilitating new as well as nationally competitive research efforts. Recruitment: Developmental moneys ($95,000) were used to assist in the recruitment of Dr. Sten Vermund (Epidemiology and International Research) from NIAID at the National Institutes of Health and Dr. Grace Aldrovandi (HIV Pathogenesis and Pediatric Experimental Therapeutics) from UCLA. In addition, the AIDS Center played a critical role in the recruitment of Drs. Laura Leviton and Ralph DiClemente (HIV Prevention Sciences/Behavioral Sciences) from the University of Pittsburgh and UCSF, respectively. As a result of these recruitments and additional resource commitments from Institutional sources, the Prevention/Behavioral Sciences Program has recruited an additional four faculty (Drs. Clark, Grimley, Pulley, and Wingood) and the Epidemiology Program has recruited two additional Faculty (Drs. Allen and Kaslow). Each of these individuals greatly enhanced the scope and capabilities of these new Research Programs. Dr. Aldrovandi has brought critical translational capabilities to our Pediatric AIDS program and the newly funded PACTU. To continue these developmental efforts, funds are requested for New Investigator Awards, Pilot Projects, and New Emerging Research Opportunities at the level of $100,000 as well as one Inter-disciplinary program at a level of $50,000. These applications will be solicited, reviewed and funded as in the past. In additional, recruitment moneys in the amount $30,000 are requested to continue to attract outstanding outside investigators to the AIDS effort. These recruitment moneys will be matched one-to-one with state funds available to the Center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027767-11
Application #
6268012
Study Section
Project Start
1998-09-01
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
11
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Salantes, D Brenda; Zheng, Yu; Mampe, Felicity et al. (2018) HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J Clin Invest 128:3102-3115
Carson, Tiffany L; Wang, Fuchenchu; Cui, Xiangqin et al. (2018) Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress. Psychosom Med 80:640-648
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Goodin, Burel R; Owens, Michael A; White, Dyan M et al. (2018) Intersectional health-related stigma in persons living with HIV and chronic pain: implications for depressive symptoms. AIDS Care 30:66-73
Bekhbat, Mandakh; Mehta, C Christina; Kelly, Sean D et al. (2018) HIV and symptoms of depression are independently associated with impaired glucocorticoid signaling. Psychoneuroendocrinology 96:118-125
Bilal, Usama; McCaul, Mary E; Crane, Heidi M et al. (2018) Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV. Alcohol Clin Exp Res 42:561-570
Nag, Mukta; Wang, Yan; De Paris, Kristina et al. (2018) Histone Modulation Blocks Treg-Induced Foxp3 Binding to the IL-2 Promoter of Virus-Specific CD8? T Cells from Feline Immunodeficiency Virus-Infected Cats. Viruses 10:
Payne, Emily H; Ramalingam, Dhivya; Fox, Donald T et al. (2018) Polyploidy and Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes in Renal Tubule Epithelial Cells. J Virol 92:
Frugé, Andrew D; Ptacek, Travis; Tsuruta, Yuko et al. (2018) Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy. J Acad Nutr Diet 118:714-723.e1
Turan, Bulent; Crockett, Kaylee B; Buyukcan-Tetik, Asuman et al. (2018) Buffering Internalization of HIV-Stigma: Implications for Treatment Adherence and Depression. J Acquir Immune Defic Syndr :

Showing the most recent 10 out of 955 publications